Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Adeshwar Meditex Ltd - 543309 - Board Meeting Outcome for Outcome Of Board Meeting Held On March 28, 2022

 With respect to the above captioned subject, we wish to inform you that as decided in the Meeting of the Board of Directors of the Company held today, i.e. on March 28, 2022, the Board of Directors has considered and approved the following: 1. To take note of authorizing Mr. Shreyas Jajoo, Manager of M/s. Adeshwar Meditex International-FZCO, UAE, Wholly Owned Subsidiary(WOS) for opening of Bank Account in the name of WOS with Emirates NBD Bank, Dubai; 2. To consider and approve policy on Corporate Social Responsibility. The Board Meeting commenced at 03:00 P.M (IST) and concluded at 03: 32 PM (IST) Thanking you,
28-03-2022
Bigul

Adeshwar Meditex Ltd - 543309 - Sub: Disclosure Under Regulation 7(2) (B) Of SEBI (Prohibition Of Insider Trading) Regulations. 2015.

 In terms of Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015, enclosed please find disclosures received from Abhinandan N, one of the insider being connected person to Whole Time Director (KMP), in Form ''C'' pursuant to Regulation 7(2)(a) read with Regulation 7(3) of SEBI (Prohibition of Insider Trading) Regulations, 2015, regarding: 1. Purchase of 12,000 equity shares of the company on 07-03-2022. Please take aforesaid disclosures on record and oblige''.
11-03-2022
Bigul

Adeshwar Meditex Ltd - 543309 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Abhinandan N
11-03-2022
Bigul

Adeshwar Meditex Ltd - 543309 - Board Meeting Outcome for Outcome Of Board Meeting Held On January 25, 2022

 Dear Sir/ Madam, With respect to the above captioned subject, we wish to inform you that as decided in the Meeting of the Board of Directors of the Company held today, i.e. on January 25, 2022, for which intimation was already given to you, the Board of Directors has considered and approved the following: 1. Approval for availing of fresh term loan under UGECL 1.0 Extension Scheme provided from Union Bank of India, Bhat Bazaar Branch to support companies liquidity affected by Pandemic. The Board Meeting commenced at 02:00 P.M (IST) and concluded at 02: 50 PM (IST)
25-01-2022
Bigul

Adeshwar Meditex Ltd - 543309 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Incorporation Of Wholly Owned Subsidiary, Dubai UAE

 Dear Sir/Madam, In continuation to outcome of Board Meeting dated September 20, 2021 with regards to incorporation of Wholly Owned Subsidiary/other subsidiaries/ Associates of the company in the Middle East Gulf Regions and European Region, we wish to inform you that the company has incorporated its Wholly Owned Subsidiary Company in Dubai, United Arab Emirates as a Free Zone Company in the name and style 'Adeshwar Meditex International, FZCO'. The intimation is given pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The above is for information and dissemination to the public at large.
20-01-2022
Bigul

Adeshwar Meditex Ltd - 543309 - Board Meeting Intimation for Intimation Of Board Meeting

 Adeshwar Meditex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2022 ,inter alia, to consider and approve We wish to inform you that the meeting of the Board of Directors of the Company will be held on Tuesday, January 25, 2022 from the Registered Office of the Company at 02:00 P.M. though VC/OAVM: To propose, consider and approve availing of fresh term loan under UGECL 1.0 Extension Scheme provided from Union Bank of India, Bhat Bazaar Branch to support companies liquidity affected by Pandemic; Any other matter with the permission of the Chair. The above intimation is given to you pursuant to relevant Regulation of the SEBI (LODR) Regulations, 2015.
18-01-2022
Bigul

Adeshwar Meditex Ltd - 543309 - Statement Of Investor Complaints For The Quarter Ended December 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Shivani TiwariDesignation :- Company Secretary and Compliance Officer
06-01-2022
Bigul

Adeshwar Meditex Ltd - 543309 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In reference to the above - captioned regulation we hereby confirm that the securities received from the depository Participants for dematerialization up to 31st December, 2021 were confirmed (accepted/rejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock exchange where the earlier issued securities are listed. We hereby confirm that the security certificates received for dematerialization have been mutilated & cancelled after due verification by the depository Participant and the name of the depositories have been substituted in register of members as registered owner within 15 days of receipt of certificate of securities. We request you to kindly take note of the above in your records.
06-01-2022
Bigul

Adeshwar Meditex Ltd - 543309 - Statement Under Regulation 32(2) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015

 Pursuant to Regulation 32(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed a statement showing any deviation or variation as on September 30, 2021 from utilization of funds raised through public issue. Kindly take the document on record and acknowledge the receipt.
12-11-2021
Bigul

Adeshwar Meditex Ltd - 543309 - Board Meeting Outcome for Outcome Of Board Meeting Dated October 29, 2021 & Results

 With the reference to the above captioned subject, we wish to intimate your esteemed exchange that as decided in the Meeting of the Board of Directors of the Company held today, i.e. Friday, October 29, 2021, at 02.00 p.m. for which intimation was already given to you: Approved and taken on record the Un-audited Financial Results along with Limited Review Report in compliance with Accounting Standards (AS) for the half year ended on September 30, 2021; The said copy of Un-audited Financial Results for the half year ended September 30, 2021 is enclosed for your needful, in pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting commenced at 02:00 P.M. (IST) and concluded at 2.55 P.M. (IST) The above is for information and dissemination to the public at large.
29-10-2021
Next Page
Close

Let's Open Free Demat Account